MTEM - スレッシュ・ホ―ルド・ファ―マス―ティカルズ （Molecular Templates Inc.） スレッシュ・ホ―ルド・ファ―マス―ティカルズMTEMのチャート
MTEMの企業情報
| symbol | MTEM |
|---|---|
| 会社名 | Molecular Templates Inc （スレッシュ・ホ―ルド・ファ―マス―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 モレキュラー・テンプレート(Molecular Templates Inc.)(旧名:Threshold Pharmaceuticals Inc.)は臨床段階のバイオテクノロジー会社である。同社はがん患者の治療のために腫瘍細胞を選択的に標的とする治療剤及び診断剤の発見・開発に従事する。同社は低酸素活性化プロドラッグ技術に基づいて、エボフォスファミド及びタルオキソチニブ2つの治療薬候補を開発する。エボフォスファミドは、腫瘍によく見られる極度の低酸素状態で活性化されるが、健康な組織では活性化されないプロドラッグとして設計される。タルオキソチニブは変異EGFR陽性、T790M陰性進行NSCLCがEGFR TKIで進行する患者、及び頭部及び頸部の再発性または転移性の扁平上皮癌の患者のためのものという2つのフェーズIIの概念実証試験で調査される。[18F] -HX4は、低酸素症を同定するための陽電子放出断層撮影イメージング剤である。 スレッシュ・ホ―ルド・ファ―マス―ティカルズは米国のバイオ医薬品会社。腫瘍微小環境（間質細胞）を研究し、抗がん剤の開発を行う。内部組織肉腫、すい臓がん、黒色腫、骨髄腫、固形腫瘍の低酸素細胞をタ―ゲットにした活性プロドラッグを治験中。また、血管新生阻害による治療法の研究を行う。 Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Its proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases. |
| 本社所在地 | 9301 Amberglen Blvd Suite 100 Austin TX 78729 USA |
| 代表者氏名 | Harold E. Selick ハロルドE.セリック |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 512-896-1555 |
| 設立年月日 | 37165 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 38人 |
| url | www.thresholdpharm.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mtem |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -32.04100 |
| 終値（lastsale） | 5.51 |
| 時価総額（marketcap） | 201088540.98 |
| 時価総額 | 時価総額（百万ドル） 171.03620 |
| 売上高 | 売上高（百万ドル） 3.31700 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 133.31120 |
| 当期純利益 | 当期純利益（百万ドル） -36.42900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Molecular Templates Inc revenues decreased 4% to $1.8M. Net loss applicable to common stockholders increased from $6.1M to $18.4M. Revenues reflect Research and development revenue decrease of 33% to $1.2M. Higher net loss reflects Rese increase from $2.3M to $13.9M (expense) General and admi increase of 33% to $5.6M (expense) Stock Based Comp- Gen_Admin Exp increase from $51K to $1.1M (expense). |
MTEMのテクニカル分析
MTEMのニュース
Oppenheimer Analysts Decrease Earnings Estimates for Molecular Templates, Inc. (NASDAQ:MTEM) 2023/04/07 05:42:46 The AM Reporter
Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) – Equities research analysts at Oppenheimer lowered their Q1 2023 EPS estimates for Molecular Templates in a research note issued to investors on Monday, April 3rd. Oppenheimer analyst F. Brisebois now forecasts that the biotechnology company will post earnings per share of ($0.33) for the quarter, down from […]
Molecular Templates GAAP EPS of -$0.39 misses by $0.09, revenue of $2.6M misses by $6.21M 2023/03/31 07:46:54 Seeking Alpha
Molecular Templates press release (MTEM): Q4 GAAP EPS of -$0.39 misses by $0.09.Revenue of $2.6M (-85.6% Y/Y) misses by $6.21M.As of December 31, 2022, MTEM’s cash and…
Is Molecular Templates Inc. (NASDAQ:MTEM) stock a better investment at this time? 2023/03/13 17:40:00 US Post News
Currently, Molecular Templates Inc.’s (MTEM) stock is trading at $0.35, marking a fall of -30.60% from last night’s close. At this price, the stock is -90.36% below its 52-week high of $3.64 and 13.10% above its 52-week low of $0.31. The 200-day Simple moving average is often placed more emphasis on by traders because of […]
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/03/10 17:58:38 Benzinga
Gainers Barnes & Noble Education, Inc. (NYSE: BNED ) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. Molecular Templates, Inc. (NASDAQ: MTEM ) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program. Jeffs'' Brands Ltd (NASDAQ: JFBR ) gained 23% to $1.7110. Jeffs'' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million. PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) gained 20.5% to $4.1814 after reporting upbeat quarterly results. Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) shares rose 19.7% to $2.47 after jumping 27% on Thursday. The company recently announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. PlayAGS, Inc. (NYSE: AGS ) shares gained 18.3% to $7.51 after the company posted better-than-expected Q4 results. Mannatech, Incorporated (NASDAQ: MTEX ) rose 18.2% to $21.00.
Nasdaq Down 50 Points; PlayAGS Shares Spike Higher 2023/03/10 17:03:49 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.21% to 32,188.00 while the NASDAQ fell 0.50% to 11,281.98. The S&P 500 also fell, dropping, 0.39% to 3,903.04. Check This Out: United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday Leading and Lagging Sectors Energy shares rose by 1.3% on Friday. Meanwhile, top gainers in the sector included Gevo, Inc. (NASDAQ: GEVO ), up 9%, and Battalion Oil Corporation (NYSE: BATL ), up 4%. In trading on Friday, real estate shares dipped by 0.6%. Top Headline The US economy unexpectedly added 311,000 jobs in February, well above market estimates of 205,000, and compared to revised 504,000 in January. The unemployment rate rose to 3.6% in February versus a 50-year low of 3.4% recorded in January. Equities Trading UP PlayAGS, Inc. (NYSE: AGS ) shares shot up 23% to $7.84 after the company posted better-than-expected Q4 results. Shares of PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) got a boost, shooting 19% to $4.1462 after reporting upbeat quarterly results.
Molecular Templates GAAP EPS of -$0.39 misses by $0.09, revenue of $2.6M misses by $6.21M 2023/03/31 07:46:54 Seeking Alpha
Molecular Templates press release (MTEM): Q4 GAAP EPS of -$0.39 misses by $0.09.Revenue of $2.6M (-85.6% Y/Y) misses by $6.21M.As of December 31, 2022, MTEM’s cash and…
Is Molecular Templates Inc. (NASDAQ:MTEM) stock a better investment at this time? 2023/03/13 17:40:00 US Post News
Currently, Molecular Templates Inc.’s (MTEM) stock is trading at $0.35, marking a fall of -30.60% from last night’s close. At this price, the stock is -90.36% below its 52-week high of $3.64 and 13.10% above its 52-week low of $0.31. The 200-day Simple moving average is often placed more emphasis on by traders because of […]
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/03/10 17:58:38 Benzinga
Gainers Barnes & Noble Education, Inc. (NYSE: BNED ) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. Molecular Templates, Inc. (NASDAQ: MTEM ) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program. Jeffs'' Brands Ltd (NASDAQ: JFBR ) gained 23% to $1.7110. Jeffs'' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million. PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) gained 20.5% to $4.1814 after reporting upbeat quarterly results. Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) shares rose 19.7% to $2.47 after jumping 27% on Thursday. The company recently announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. PlayAGS, Inc. (NYSE: AGS ) shares gained 18.3% to $7.51 after the company posted better-than-expected Q4 results. Mannatech, Incorporated (NASDAQ: MTEX ) rose 18.2% to $21.00.
Nasdaq Down 50 Points; PlayAGS Shares Spike Higher 2023/03/10 17:03:49 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.21% to 32,188.00 while the NASDAQ fell 0.50% to 11,281.98. The S&P 500 also fell, dropping, 0.39% to 3,903.04. Check This Out: United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday Leading and Lagging Sectors Energy shares rose by 1.3% on Friday. Meanwhile, top gainers in the sector included Gevo, Inc. (NASDAQ: GEVO ), up 9%, and Battalion Oil Corporation (NYSE: BATL ), up 4%. In trading on Friday, real estate shares dipped by 0.6%. Top Headline The US economy unexpectedly added 311,000 jobs in February, well above market estimates of 205,000, and compared to revised 504,000 in January. The unemployment rate rose to 3.6% in February versus a 50-year low of 3.4% recorded in January. Equities Trading UP PlayAGS, Inc. (NYSE: AGS ) shares shot up 23% to $7.84 after the company posted better-than-expected Q4 results. Shares of PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) got a boost, shooting 19% to $4.1462 after reporting upbeat quarterly results.
Why Is Molecular Templates (MTEM) Stock Up 36% Today? 2023/03/10 13:01:57 InvestorPlace
Molecular Templates (MTEM) stock is rocketing higher on Friday after the company got approval from the FDA for a clinical trial.
Looking Into Molecular Templates''s Return On Capital Employed 2022/12/22 14:49:38 Benzinga
Molecular Templates (NASDAQ: MTEM ) brought in sales totaling $4.24 million during Q3 according to data provided by Benzinga Pro . However, earnings decreased 0.89%, resulting in a loss of $24.64 million. Molecular Templates collected $4.42 million in revenue during Q2, but reported earnings showed a $24.42 million loss. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and … Full story available on Benzinga.com
Molecular Templates Earnings, Revenue Beat in Q3 By Investing.com 2022/11/11 05:59:00 Investing.com
Molecular Templates Earnings, Revenue Beat in Q3
Molecular Templates GAAP EPS of -$0.44 beats by $0.04, revenue of $4.24M beats by $1.16M (NASDAQ:MTEM) 2022/11/10 22:11:53 Seeking Alpha
Molecular Templates press release (NASDAQ:MTEM): Q3 GAAP EPS of -$0.44 beats by $0.04.Revenue of $4.24M (+78.2% Y/Y) beats by $1.16M.
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results 2022/11/10 21:15:00 GlobeNewswire
AUSTIN, Texas, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases, today reported financial results and business updates for the third quarter of 2022.